Licensing opportunity: Antibody specific for DNA/RNA hybrids

Monoclonal Antibody Specific for DNA/RNA Hybrid Molecules | Office of Technology Transfer, NIH

 Licensing opportunity: Antibody specific for DNA/RNA hybrids

A technician's hand filling wells with a liquid for a research test. This test involves preparation of cultures in which hybrids are grown in large quantities to produce desired antibody. Photo credit: National Cancer Institute

NIAID has a hybridoma available for licensing that produces a monoclonal antibody specific for DNA/RNA hybrids. This is the only available monoclonal antibody specific for DNA/RNA hybrids. In addition to being used as a research reagent, this antibody could be used in diagnostic kits for viral/bacterial infections, cancers, and a variety of other human diseases. Read more about this exciting licensing opportunity at https://www.ott.nih.gov/technology/e-738-2013.